Autres langues DURECT Corporation

Actions

DRRX

US2666055007

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 10/05/2024			Varia. 5j.	Varia. 1 janv.
1,06 ^USD	-6,19%		-8,62%	+79,66%

27/03	Transcript : DURECT Corporation, Q4 2023 Earnings Call, Mar 27, 2024
27/03	DURECT Corporation présente ses résultats pour l'année complète terminée le 31 décembre 2023	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

DURECT Corporation to Announce First Quarter 2024 Financial Results and Provide a Business Update	07/05
DURECT Corporation Announces Late-Breaking Oral Presentation at the EASL Congress 2024 to Discuss AHFIRM Phase 2b Data in Alcohol-Associated Hepatitis	30/04
Durect: Q4 Earnings Snapshot	27/03
DURECT Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	27/03
Earnings Flash (DRRX) DURECT CORPORATION Posts Q4 Revenue $2.7M, vs. Street Est of $2.7M	27/03
DURECT Corporation Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update	27/03
DURECT Corporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	27/03
North American Morning Briefing : Stocks Edge -2-	27/03
DURECT Corporation to Announce Fourth Quarter and Full Year 2023 Financial Results and Provide a Business Update	20/03
North American Morning Briefing : Stock Futures -2-	19/03
DURECT and Charles River Laboratories Enter into Co-Marketing and Collaboration Agreement for ALZET® Product Line in U.S. and Canada	04/03
DURECT Corporation and Charles River Laboratories Enter into Co-Marketing and Collaboration Agreement for Alzet® Product Line in U.S. and Canada	04/03
DURECT Corporation to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference	08/02
DURECT Corporation(NasdaqCM:DRRX) dropped from S&P Global BMI Index	18/12
Durect: Q3 Earnings Snapshot	13/11
Earnings Flash (DRRX) DURECT CORPORATION Reports Q3 Revenue $1.7M, vs. Street Est of $2.5M	13/11
DURECT Corporation Reports Third Quarter 2023 Financial Results and Business Update	13/11
DURECT Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	13/11
North American Morning Briefing : Investors Weigh -2-	10/11
DURECT Corporation to Announce Third Quarter 2023 Financial Results and Provide a Business Update	09/11

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues DURECT Corporation

Actions

DRRX

US2666055007

Autres langues

Filtres